Protagonist Therapeutics, Inc
Symbol: PTGX (NASDAQ)
63.00
▼ (-3.05%) -1.980
Company Description:
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Key Stats
- Today's Open: $64.899
- Today's High: $64.899
- Today's Low: $62.3
- Today's Volume: 4
- Yesterday Close: $64.98
- Yesterday High: $65.5
- Yesterday Low: $63.71
- Yesterday Volume: 575.46K
- Last Min Volume: 0
- Last Min High: $63
- Last Min Low: $62.417
- Last Min VWAP: $0
Company Profile
- Name: Protagonist Therapeutics, Inc
- Website: https://www.protagonist-inc.com
- Listed Date: 2016-08-11
- Location: NEWARK, CA
- Market Status: Active
- CIK Number: 0001377121
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.04B
- Round Lot: 100
- Outstanding Shares: 62.21M
- Asset Type: CS
RECENT FILINGS FOR PTGX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-24 | 4 | View |
| 2025-09-22 | 144 | View |
| 2025-09-18 | 4 | View |
| 2025-08-29 | 4 | View |
| 2025-08-27 | 144 | View |
| 2025-08-11 | SCHEDULE 13G | View |
| 2025-08-06 | S-3ASR | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-28 | 4 | View |
| 2025-07-23 | 4 | View |
| 2025-07-22 | 144 | View |
| 2025-07-18 | 4 | View |
| 2025-06-26 | 8-K | View |
| 2025-06-17 | 4 | View |
| 2025-06-16 | SCHEDULE 13G | View |
| 2025-06-11 | 4 | View |
| 2025-06-10 | 144 | View |
| 2025-06-09 | 144 | View |
| 2025-05-13 | SCHEDULE 13G | View |
Latest News on PTGX